Past Speakers - Riker Lecture
| Date | Speaker | Topic | |
| February 11, 2010 |
Larry Marnett, Ph.D. Mary Geddes Stahlman Professor of Cancer Research; Professor of Biochemistry;Professor of Chemistry Vanderbilt University |
||
| January 15, 2009 |
Allan Rettie, Ph.D. Professor and Chair, Department of Medicinal Chemistry University of Washington |
"Warfarin Pharmacogenomics: A Model for Personalized Medicine" | |
| January 30, 2008 | David Colquhoun, Ph.D. Department of Pharmacology University College London |
On the nature of partial agonism: single channels allow a new way of looking at an old problem |
|
| January 24, 2007 | Dr. Garret A. FitzGerald, M.D. Chair, Department of Pharmacology Director, Center for Experimental Therapeutics & Clinical Research Center Director, Institute for Translational Medicine & Therapeutics University of Pennsylvania, Philadelphia, PA |
Cyclooxygenases: Their Products and Inhibitors | |
| February 1, 2006 | Bert W. O'Malley, M.D. Tom Thompson Professor and Chair, Department of Molecular and Cellular Biology Director, Baylor Center for Reproductive Biology Baylor College of Medicine, Houston, TX |
The Biological and Medical Implications of Steroid Receptor Coactivators | |
| February 2, 2005 | Bradley J. Undem, Ph.D. Professor of Medicine Department of Medicine at John Hopkins University |
Pharmacology of Vagal Sensory Nerve Activation | |
| February 18, 2004 | D. James Surmeier, Jr., Ph.D. Professor and Chair, Department of Physiology Northwestern University Medical School, Chicago, IL |
The Mystery of Postsynaptic D2 Receptor Signaling in the Striatum | |
| January 15, 2003 | Darrell R. Abernethy, M.D., Ph.D. Chief, Laboratory of Clinical Investigation, National Institute on Aging, National Institutes of Health Professor of Medicine and Pharmacology and Molecular Science, John Hopkins Univ. School of Medicine |
Structural Diversity of the L-Type Calcium Channel: Relating Structure to Function for Pharmacology and Physiology | |
| February 20, 2002 | Brian Druker, M.D. Director of the Leukemia Center Oregon Cancer Institute, OHSU |
Targeted Cancer Therapies: Lessons Learned from ST1571 and Chronic Mylogenous Leukemia | |
| June 6, 2001 | Ronald Evans, Ph.D. March of Dimes Chair in Developmental and Molecular Biology and Professor in the Gene Expression Laboratory The Salk Institute for Biological Studies Investigator, Howard Hughes Medical Institute |
Nuclear Receptors, SXR and the Xenobiotic Response | |
| January 19, 2000 | Robert Freedman, M.D. Human Medical Genetics Program University of Colorado Health Sciences Center |
Nicotinic Receptors in Schizophrenia | |
| January 28, 1999 | Frances M. Leslie, Ph.D. Professor, Department of Pharmacology and Anatomy and Neurobiology Director, Transdisciplinary Tobacco Use Research Center University of California, Irvine |
The Influence of Nicotine on Brain Development | |
| January 21, 1998 | Barry J. Hoffer, M.D., Ph.D. Chief, Cellular Neurophysiology Section, Intramural Research Section, National Institute on Drug Abuse |
Glial Cell Line-Derived Neurotrophic Factor and Dopamine Neurons | |
| October 23, 1996 | Hazel Hon Szeto, M.D., Ph.D. Professor of Pharmacology Weill Cornell Medical College, Cornell University |
Mechanisms of Dynorphin-Mediated Release of Adrenocorticotrophin | |
| September 14, 1995 | Raymond L. Woosley, M.D., Ph.D. Professor and Chair, Department of Pharmacology Georgetown University School of Medicine |
Prescriptions, Pills and Blind Faith | |
| April 28, 1994 | V. Craig Jordan, Ph.D., D.Sc Professor of Cancer Pharmacology Director, Breast Cancer Research Program, Robert H. Lurie Comprehensive Cancer Center Northwestern University Medical School |
Antiestrogens: Targeted Tools in Molecular Biology and Therapeutic Applications for Breast Cancer, Coronary Heart Disease and Osteoporosis | |
| May 13, 1993 | F. Peter Guengerich, Ph.D. Professor of Biochemistry Director, Center in Molecular Toxicity Vanderbilt University School of Medicine |
Human Cytochrome p450 Enzymes: Characterization, Properties and Relevance to Drug Metabolism and Efficacy | |
| May 21, 1992 | R. Alan North, M.D., Ph.D. | Potassium Channels: The First 50 Years and the Last 5 Months | |
| May 23, 1991 | William W. Fleming, Ph.D. Professor of Pharmacology West Virginia University School of Medicine |
Adaptation of Myenteric Neurons to Chronic Exposure to Morphine | |
| April 26, 1990 | Elliot S. Vesell, M.D. Professor and Chair, Department of Pharmacology Pennsylvania State University College of Medicine |
Causes and Consequences of Variations in Drug Response | |
| April 13, 1989 | Sydney Spector, Ph.D. Professor of Psychiatry and Pharmacology Vanderbilt University School of Medicine |
Presence of Endogenous Opiate Alkaloids in Mammalian Tissues | |
| May 19, 1988 | Joseph Larner, M.D., Ph.D. Professor and Chair, Department of Pharmacology University of Virginia |
Insulin Signaling Mechanisms: Altered Polypeptide Phosphorylation and Mediator Production | |
| May 21, 1987 | Robert F. Furchgott, Ph.D. Professor Emeritus of Pharmacology SUNY Health Science Center, Brooklyn, NY |
Endothelium-Dependent Vasodilation and the Endothelium-Derived Relaxing Factor | |
| May 15, 1986 | Philip Needleman, Ph.D. Professor and Chair, Department of Pharmacology Washington University School of Medicine |
Atriopeptins: Cardiac Hormones Involved in Fluid, Electrolyte, and Blood Pressure Regulation | |
| October 11, 1984 | Paul Calabresi, M.D. Professor and Chair, Department of Medicine, Brown University Director, Brown University Cancer Center |
Cancer: Crab or Chimera? The Clinical Implications of Cancer Cell Heterogeneity | |
| May 19, 1983 | Avram Goldstein, M.D. Professor of Pharmacology Director, Addiction Research Foundation Stanford University |
The Dynorphin Peptins and the Kappa Opioid Receptor | |
| May 12, 1982 | Walter F. Riker, Jr., M.D. Professor and Chair, Department of Pharmacology Weill Medical College, Cornell University |
Reflections on Pharmacologic and Other Effects of Curare |
